RT @DrHebaMD: Patients with IMID are at increased risk of CV disease and though mortality has decreased women don’t fair as well. It takes….

Great honor to be invited to ⁦@OhioACC⁩ FITGrand Rounds discussing CV manifestations of RA and increased CV risk ⁦@EllenSabik⁩ ⁦⁩ thanks Dr. Barbadora ⁦@ACCinTouch⁩ ⁦@CleClinicHVTI⁩ ⁦@LarsSvenssonMD⁩

Patients with IMID are at increased risk of CV disease and though mortality has decreased women don’t fair as well. It takes a village from primary care to rheumatology and cardiology # cardiorheum @CleClinicHVTI @tavrkapadia @LarsSvenssonMD @ACCinTouch @OhioACC @IMotairek.

RT @lamckeown1: "We need to look at these patients differently than we have in the past and try to fill some of these gaps in understanding….

Outstanding presentation ⁦@zohamajeed⁩ on adding malignancy to CHADsVASC score in cancer patient .⁦@DrRohitMoudgil⁩ congratulations on your mentorship ⁦@CCF_IMCHIEFS⁩ ⁦@tavrkapadia⁩ ⁦@LarsSvenssonMD⁩ ⁦@CleClinicHVTI⁩

Women with common autoimmune diseases may face higher death rate from heart disease, stroke than men | American Heart Association ⁦@IMotairek⁩ ⁦@CCF_IMCHIEFS⁩ ⁦@CCFcards⁩ . Lots of national interest to bring attention to IMID#cardiorheum

RT @IMotairek: 🚨 Great work from our Cardio-Rheumatology Center: Over 22 years, CV mortality in IMID patients fell but women still faced ~5….

Sex Differences in Cardiovascular Mortality Among Patients With Immune Mediated Inflammatory Diseases | Circulation: Cardiovascular Quality & Outcomes #cardiorheumatology ⁦@CleClinicHVTI⁩ ⁦@LarsSvenssonMD⁩ ⁦⁩ ⁦@CCF_IMCHIEFS⁩

Missing ⁦@akates1⁩ with ⁦@mmartinezheart⁩ ⁦@OhioACC⁩ a week after ACC Advanced Educator ⁦@ACCinTouch⁩

Great to see ⁦@mmartinezheart⁩ ⁦@OhioACC⁩ ⁦@ash71us⁩ . Fantastic, informative and practical talk on HCM. Echo be ware of MR and goal directed Valsalva are key in the diagnosis ⁦@ACCinTouch⁩ ⁦@CleClinicMD⁩

⁦@mmartinezheart⁩ educating ⁦@OhioACC⁩ about HCM. We don’t diagnose HCM because we don’t think about . AI will not be the windfall we still have to be clinicians.wall thickness >1.5 it’s not likely hypertension ⁦@ACCinTouch⁩ ⁦⁩ ⁦@ash71us⁩

⁦@CCFcards⁩ ⁦@CleClinicHVTI⁩ KimberlyChow presenting ⁦@OhioACC⁩ on FINEARTS-HF trial. Finerenone in HF> 40% CV death and total HF events were the primary end point .Finerenone reduced HF events but not mortality. Safety outcomes no deaths but higher K.

RT @mmartinezheart: @DrHebaMD @OhioACC meeting. Amazing talk on cardio Rheum. Novel talk techniques. CHATGPT throughout. Engaged audience.….

Dr. Heather Gornik author of ACC PVD guidelines urging cardiologist to read the guidelines and take of patients socks to evaluate pulses and ulcers ⁦@OhioACC⁩ ⁦@EllenSabik⁩ ⁦@ACCinTouch⁩ ⁦@PulkitChaudhury⁩

I am speaking at Ohio-ACC Spring Summit 2025. Please check out my talk if you're attending the event! - via #Whova event app

So proud of the work that Sam Kelly and I have done on impact on SGL2i in SLE and HF #cardiorheumatology @CCFcards @CleClinicHVTI @LarsSvenssonMD @tavrkapadia.

RT @CCFcards: We’re excited to celebrate our finalists’ research presentations on May 8! We’re also looking forward to welcoming CCF Cards….

RT @mmartinezheart: @DrHebaMD @ACCinTouch @akates1 @DrAmyPollak @MehnazRahmanMD @NicoleBhaveMD @LarsSvenssonMD Excellent course!.

Thank you @AkivaRosenzveig for your kindness.

An honor to receive an Academy of Scholar Educator award ⁦@CCF_IMCHIEFS⁩ ⁦@CleClinicMD⁩ ⁦@ClevelandClinic⁩ ⁦@CleClinicHVTI⁩ ⁦@LarsSvenssonMD⁩ ⁦@tavrkapadia⁩ ⁦@venumenon10⁩